Using the best drug first to avoid mutations has always seemed to me to be logical. Resistance by oncologists just is laziness (putting aside possible Novartis bribery etc).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.